Literature DB >> 23756662

Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.

Yoko Okuno1, Kazuhiko Sakaguchi, Hisako Komada, Naoko Hashimoto, Yushi Hirota, Tomoaki Nakamura, Wataru Ogawa, Susumu Seino.   

Abstract

Evaluating insulin secretion ability and sensitivity is essential to establish an appropriate treatment for patients with type 2 diabetes. The serum C-peptide response (CPR) level is used to evaluate the quantity of endogenous insulin secretion. However, the serum CPR level alone cannot indicate insulin-secretion ability or insulin sensitivity, because plasma glucose levels influence endogenous insulin secretion and vice versa. The CPR index, a ratio of serum CPR level to plasma glucose concentration when measured simultaneously, was previously reported to be a useful marker to determine the necessity of insulin treatment in patients with type 2 diabetes, but the reasons are unknown. The aim of this study was to clarify which factors affect the CPR index in patients with type 2 diabetes. Totally, 121 subjects were included in this study; all participants were hospitalized for type 2 diabetes. On the day after admission, we calculated the CPR index from each patient's fasting blood sample and a blood sample taken 2 hours after breakfast (the postprandial sample). A detailed medical history was taken from each patient to establish the disease duration. The degree of diabetic retinopathy judged by an ophthalmologist was obtained from patients' medical records. An oral glucose tolerance test and a glucagon load test were performed after the fasting plasma glucose level decreased to 130 mg/dl, and indices of insulin secretion and sensitivity were calculated. Fasting and postprandial CPR indices were moderately correlated with total endogenous insulin secretion after oral glucose load and with the CPR level after glucagon load, insulin sensitivity, composite index, and the reciprocal index of homeostasis model assessment (HOMA-R-1). Furthermore, there was a weak but significant correlation between the postprandial CPR index and the duration of diabetes. The postprandial CPR index was inversely correlated with the degree of diabetic retinopathy, which is known to be associated with the duration of hyperglycemia. Our data clearly shows that the CPR index is a useful parameter to reflect the degree of impaired glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756662

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  5 in total

1.  EFFECT OF HIGH-DOSE VITAMIN D REPLETION ON GLYCEMIC CONTROL IN AFRICAN-AMERICAN MALES WITH PREDIABETES AND HYPOVITAMINOSIS D.

Authors:  Elena Barengolts; Buvana Manickam; Yuval Eisenberg; Arfana Akbar; Subhash Kukreja; Irina Ciubotaru
Journal:  Endocr Pract       Date:  2015-02-25       Impact factor: 3.443

2.  Perioperative C-peptide index is associated with the status of diabetes management after pancreatectomy.

Authors:  Masataka Shikata; Daisuke Chujo; Asako Enkaku; Akiko Takikawa-Nishida; Hisae Honoki; Shinnosuke Yamada-Matsukoshi; Maki Nakagawa-Yokoyama; Miki Kamigishi; Shinya Inagawa; Shiho Fujisaka; Kunimasa Yagi; Kazuto Shibuya; Tsutomu Fujii; Kazuyuki Tobe
Journal:  J Diabetes Investig       Date:  2022-06-28       Impact factor: 3.681

3.  Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial.

Authors:  Akiko Kameda; Akinobu Nakamura; Yoshinobu Kondo; Mari Kimura; Yasuo Terauchi
Journal:  Diabetol Int       Date:  2017-07-05

4.  Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.

Authors:  Hisao Wakasaki; Takeshi Shono; Ryutaro Nakao; Shohei Yamamoto; Takamasa Minaga; Sakiko Fukuda; Reika Matsumoto; Takashi Ohoshi; Keigo Naka; Kishio Nanjo
Journal:  Intern Med       Date:  2020-09-15       Impact factor: 1.271

5.  Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Authors:  Ryota Usui; Yui Sakuramachi; Yusuke Seino; Kenta Murotani; Hitoshi Kuwata; Hisato Tatsuoka; Yoshiyuki Hamamoto; Takeshi Kurose; Yutaka Seino; Daisuke Yabe
Journal:  J Diabetes Investig       Date:  2017-12-13       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.